Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates

SIMPLE SUMMARY: Small-cell lung cancer (SCLC) represents a highly aggressive form of lung cancer. Although SCLC initially responds to chemoimmunotherapy, it inevitably relapses. Antibody–drug conjugates (ADCs) have emerged as a promising treatment approach. ADCs consist of antibodies targeting speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Belluomini, Lorenzo, Sposito, Marco, Avancini, Alice, Insolda, Jessica, Milella, Michele, Rossi, Antonio, Pilotto, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670928/
https://www.ncbi.nlm.nih.gov/pubmed/38001628
http://dx.doi.org/10.3390/cancers15225368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670928/
https://www.ncbi.nlm.nih.gov/pubmed/38001628
http://dx.doi.org/10.3390/cancers15225368

Ejemplares similares